Patents by Inventor Gregory DUBÉ

Gregory DUBÉ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210386831
    Abstract: The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Application
    Filed: June 1, 2021
    Publication date: December 16, 2021
    Inventors: Jeffrey I. JOSEPH, Richard William BERENSON, Bruce FRANK, Michael A. WEISS, Thomas HATTIER, Gregory DUBÉ, Zhiqiang CHEN
  • Publication number: 20200138911
    Abstract: The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Application
    Filed: January 2, 2020
    Publication date: May 7, 2020
    Inventors: Jeffrey I. JOSEPH, Richard William BERENSON, Bruce FRANK, Michael A. WEISS, Thomas HATTIER, Gregory DUBÉ, Zhiqiang CHEN
  • Patent number: 10561711
    Abstract: The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: February 18, 2020
    Assignee: THERMALIN, INC.
    Inventors: Richard William Berenson, Bruce Frank, Michael A. Weiss, Thomas Hattier, Gregory Dubé, Zhiqiang Chen
  • Publication number: 20180243380
    Abstract: The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Application
    Filed: January 12, 2018
    Publication date: August 30, 2018
    Inventors: Jeffrey I. JOSEPH, Richard William BERENSON, Bruce FRANK, Michael A. WEISS, Thomas HATTIER, Gregory DUBÉ, Zhiqiang CHEN
  • Patent number: 9901622
    Abstract: The present invention provides rapid-acting insulin and insulin analog formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogs, as well as other active agents. Methods of using the insulin and insulin analog formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Grant
    Filed: January 13, 2015
    Date of Patent: February 27, 2018
    Assignee: THERMALIN DIABETES, INC.
    Inventors: Jeffrey I. Joseph, Richard William Berenson, Bruce Frank, Michael A. Weiss, Thomas Hattier, Gregory Dubé, Zhiqiang Chen
  • Publication number: 20160375104
    Abstract: The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
    Type: Application
    Filed: January 13, 2015
    Publication date: December 29, 2016
    Inventors: Jeffrey I. JOSEPH, Richard William BERENSON, Bruce FRANK, Michael A. WEISS, Thomas HATTIER, Gregory DUBÉ, Zhiqiang CHEN